课题基金 / 基金详情

Burden of disease: Costing an effective package of care for mental disorders

Burden of disease: Costing an effective package of care for mental disorders
疾病负担:精神障碍有效护理方案的成本
批准号:
nhmrc : 113807
负责人:
Prof Gavin Andrews
金额:
$18.19万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2000
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2000-01-01 至 2002-12-31

项目摘要

项目成果

Prof Gavin Andrews的其他基金

相似基金

相关文献

中文摘要
翻译
世卫组织-世界银行-哈佛大学合作的全球疾病负担项目展示了发达国家和发展中国家全球卫生状况的前所未有的图景,为规划卫生服务提供了急需的信息。健康是在人口水平上衡量的,并结合因死亡和残疾而损失的寿命年数,得出每个疾病损失的生命总量。该项目的一个令人惊讶的地方是精神障碍的重要性,在澳大利亚等国家,精神障碍占因残疾而损失的寿命年的43%。减少这一负担的服务规划需要了解具有成本效益的治疗方法。这项计划将试验一种用于结合负担和成本效益数据的方法,以设计一套基本的服务,以解决精神障碍的治疗短缺问题。这项研究将有助于我们理解为什么精神障碍造成的负担仍然存在,以及目前的治疗知识在多大程度上能够在现有预算限制的范围内解决这一负担。这将通过以下方式实现:1)详细说明澳大利亚目前为精神障碍提供的服务的成本和人群结果,以确定哪些疾病目前已得到充分治疗,哪些疾病需要进一步干预;2)根据临床实践指南计算最佳实践干预的成本和结果,以了解目前的治疗知识可以在多大程度上减轻因精神障碍造成的负担;3)检查这样一套理想干预措施的公平后果,了解治疗终点并不适用于所有疾病。这是一个二次分析,代表了一种将个别治疗的现有成本和结果数据转化为其在人口一级的卫生规划的成本和后果的方法。
英文摘要
The Global Burden of Disease project, a WHO-World Bank-Harvard collaboration, presented an unprecedented picture of global health across the developed and developing world, providing much-needed information for planning health services. Health was measured at the population level, and combined the number of life years lost due to death and disablement to give a total amount of life lost per disorder. One surprise of the project was the importance of mental disorders, accounting for 43% of life years lost due to disability in countries like Australia. Service planning to reduce this burden requires knowledge of cost-effective treatments.This project will trial a method used for combining burden and cost-effectiveness data to design an essential package of services to address the treatment shortfall in mental disorders. This research will assist in our understanding of why burden due to mental disorders persists, and the extent to which current treatment knowledge is able to address this burden within existing budgetary constraints. This will be achieved by: 1) detailing the costs and population outcome of current services in Australia for mental disorders, to determine which disorders are currently adequately treated and which disorders require further intervention, 2) calculating the costs and outcome of best practice interventions from clinical practice guidelines, to understand the extent to which current treatment knowledge can reduce burden due to mental disorders, 3) examining the equity consequences of such a package of ideal interventions, with the understanding that the treatment endpoint is not the same for all disorders. This is a secondary analysis, representing a method for translating existing cost and outcome data for individual treatments into their costs and consequences for health planning at the population level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Risk factors, early diagnosis, and effective interventions for neurocognitive disorders
  • 批准号:
    nhmrc : 1093083
  • 项目类别:
    Program Grants
  • 资助金额:
    $467.65万
  • 财政年份:
    2016
  • 负责人:
    Prof Gavin Andrews
  • 依托单位:
Risk factors, early diagnosis, and effective interventions for neurocognitive disorders
  • 批准号:
    nhmrc : GNT1093083
  • 项目类别:
    Programs
  • 资助金额:
    $678.27万
  • 财政年份:
    2016
  • 负责人:
    Prof Gavin Andrews
  • 依托单位:
Prevention, early detection and effective management of neurocognitive disorders in the elderly
  • 批准号:
    nhmrc : 568969
  • 项目类别:
    Programs
  • 资助金额:
    $436.62万
  • 财政年份:
    2009
  • 负责人:
    Prof Gavin Andrews
  • 依托单位:
Prevention and management of mental disorders in older Australians
  • 批准号:
    nhmrc : 568940
  • 项目类别:
    Capacity
  • 资助金额:
    $165.8万
  • 财政年份:
    2009
  • 负责人:
    Prof Gavin Andrews
  • 依托单位:
国内基金
海外基金
黏液层/细菌被膜双重渗透型抗菌聚多肽纳米载体用于肺部给药治疗慢性阻塞性肺病
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    虞桂平
  • 依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹立
  • 依托单位:
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
  • 批准号:
    82371801
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    周海波
  • 依托单位:
肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
  • 批准号:
    82372306
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    彭奕冰
  • 依托单位: